Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University. Xi'an, China.
Department of Neurosurgery, Xi'an International Medical Center, Xi'an, Shaanxi, China.
Int J Med Sci. 2020 Jun 21;17(11):1541-1549. doi: 10.7150/ijms.46403. eCollection 2020.
To prospectively evaluate the efficacy of a neurosurgical enhanced recovery after surgery (ERAS) protocol on the management of postoperative pain after elective craniotomies. This randomized controlled trial was conducted in the neurosurgical center of Tangdu Hospital (Fourth Military Medical University, Xi'an, China). A total of 129 patients undergoing craniotomies between October 2016 and July 2017 were enrolled in a randomized clinical trial comparing an ERAS protocol to a conventional postoperative care regimen. The primary outcome was the postoperative pain score assessed by a verbal numerical rating scale (NRS). Patients in the ERAS group had a significant reduction in their postoperative pain scores on POD 1 compared to patients in the control group (p < 0.05). More patients (n = 44, 68.8%) in the ERAS group experienced mild pain (NRS: 1 to 3) on POD1 compared with patients (n = 23, 35.4%) in the control group (p < 0.05). A further reduction in pain scores was also observed on POD 2 and maintained on POD 3 in the ERAS group compared with that in the control group. In addition, the median postoperative length of hospital stay was significantly decreased with the incorporation of the ERAS protocol compared to controls (ERAS: 4 days, control: 7 days, P<0.001). The implementation of a neurosurgical ERAS protocol for elective craniotomy patients has significant benefits in alleviating postoperative pain and enhancing recovery leading to early discharge after surgery compared to conventional care. Further evaluation of this protocol in larger, multi-center studies is warranted.
前瞻性评估神经外科术后加速康复(ERAS)方案在择期开颅术后管理中对术后疼痛的疗效。这项随机对照试验在唐都医院神经外科中心(第四军医大学,西安,中国)进行。共有 129 名 2016 年 10 月至 2017 年 7 月期间接受开颅术的患者被纳入一项比较 ERAS 方案与常规术后护理方案的随机临床试验。主要结局是通过数字评分量表(NRS)评估的术后疼痛评分。ERAS 组患者在术后第 1 天的术后疼痛评分明显低于对照组(p < 0.05)。与对照组相比(n = 23,35.4%),ERAS 组更多的患者(n = 44,68.8%)在术后第 1 天(NRS:1-3)体验到轻度疼痛(p < 0.05)。与对照组相比,ERAS 组在术后第 2 天和第 3 天疼痛评分进一步降低。此外,与对照组相比,纳入 ERAS 方案后术后住院时间中位数明显缩短(ERAS:4 天,对照组:7 天,P <0.001)。与常规护理相比,为择期开颅术患者实施神经外科 ERAS 方案在缓解术后疼痛和促进术后早期出院方面具有显著优势。需要进一步在更大、多中心的研究中评估该方案。